[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336756-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336756-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","first-reported-case-of-primary-small-cell-cancer-of-the-pancreas-with-positive-ttf-1-tumor-marker-case-report","First reported case of primary small cell cancer of the pancreas with positive TTF-1 tumor marker - Case report","","Small cell carcinomas are highly aggressive malignancies usually linked to lung cancer, but they can arise in the pancreas and other organs. Pancreatic small cell carcinoma (about 1% of such neoplasms) is rare and often metastatic at diagnosis, leading to limited options and poor outcomes. An 88-year-old man with major comorbidities and marked weight loss was diagnosed with metastatic pancreatic neuroendocrine carcinoma after persistent epistaxis and back pain. The case highlights atypical tumor-marker use, including TTF-1, and supports multidisciplinary, patient-centered management.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/first-reported-case-of-primary-small-cell-cancer-of-the-pancreas-with-positive-ttf-1-tumor-marker-case-report/336756/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/first-reported-case-of-primary-small-cell-cancer-of-the-pancreas-with-positive-ttf-1-tumor-marker-case-report/336756.png","ImageObject",300,407,{"name":42,"@type":43},"Miles","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the case report focus on regarding pancreatic small cell cancer?","Question",{"text":63,"@type":64},"It presents the first reported case of primary small cell cancer of the pancreas with positive TTF-1 tumor-marker findings and discusses the diagnostic significance of this atypical marker.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why is TTF-1 important in diagnosing this case?",{"text":68,"@type":64},"TTF-1 is typically associated with lung and thyroid cancers, so its presence in a pancreatic tumor creates a diagnostic challenge. The report emphasizes careful interpretation of tumor markers in atypical small-cell presentations.",{"name":70,"@type":61,"acceptedAnswer":71},"What clinical features led to the diagnostic workup?",{"text":72,"@type":64},"The patient had persistent epistaxis and back pain with substantial weight loss, along with abnormal laboratory results and imaging evidence of a pancreatic mass with biliary obstruction and extensive metastases.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336756,1790949523,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":97,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Radiology Ca s e Reports 19 (2024) 5595 – 5599  \nAvailable online [at](at www.sciencedirect.com)[ www.sciencedirect.com](at www.sciencedirect.com)  \njournal [homepage:](homepage: www.elsevier.com/locate/radcr)[ www.elsevier.com/locate/radcr](homepage: www.elsevier.com/locate/radcr)  \n| Case Report\u003Cbr>First reported case of primary small cell cancer of the pancreas with positive TTF-1 tumor marker ✩,✩✩\u003Cbr>Hasan Al-Obaidia, Pratiksha Moliyaa, Ahmed Dheyaa Al-Obaidib, Hussein Harbc, Sajjad Ghanim Al-Badrib,∗, Hashim Talib Hashimd, Iya Aghae, Maximo Moraa, Nooraldin Merzaf, Assalah Othmang, Avani Patela\u003Cbr>a Department of Medicine, Jamaica Hospital Medical Center, New York City, NY, USA b Department of Internal Medicine, University of Baghdad, College of Medicine, Baghdad, Iraq c Department of Internal Medicine, Ross University School of Medicine, Bridgetown, Barbados d Research Department, University of Warith Al-Anbiyaa, College of Medicine, Karbala, Iraq\u003Cbr>e Department of Internal Medicine, New York Institute of Technology, College of Osteopathic Medicine, Westbury NY, USA\u003Cbr>f Department of Internal Medicine, The University of Toledo Medical Center, Toledo, OH, USA g Pharmacy Department, D’Youville University School of Pharmacy, Buffalo, NY, USA |  |\n| --- | --- |\n| a r t i c l e i n f o | a b s t r a c t\u003Cbr>Small cell carcinomas are very aggressive malignancies that are most often linked with lung cancer, although they may also develop in the pancreas, colon, rectum, skin, and cervix. SCCof the pancreas accounts for about 1% of these neoplasms. An 88-year-old male with several comorbidities who presented with significant weight loss was diagnosed with metastatic pancreatic neuroendocrine carcinoma after complaining of persistent epistaxis and back pain. This case underscores the significance of using atypical tumor markers, such as thyroid transcription factor 1, to diagnose small-cell pancreatic cancer. It also emphasizes the importance of a multidisciplinary, patient-centered approach to managing these aggressive tumors.\u003Cbr>© 2024 The Authors. Published by Elsevier Inc. on behalf of University of Washington.\u003Cbr>This is an open access article under the CC BY-NC-ND license\u003Cbr>([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)) |\n| Article history:\u003Cbr>Received 24 July 2024 Revised 6 August 2024 Accepted 8 August 2024 |  |\n| Keywords:\u003Cbr>Small cell carcinoma of pancreas Neuroendocrine differentiation Thyroid transcription factor-1 Metastatic disease\u003Cbr>Tumor markers |  |\n\n18%-20% of all cases. Unusual locations for SCCs include the pancreas, colon, rectum, skin, and cervix [1] . Small cell carcinoma of the pancreas (SCCP) is very rare, representing only 1% of small cell or neuroendocrine malignant neoplasms in this organ. SCCP is a very aggressive tumor, and hence, it has an  \n✩ Competing Interests: We declare that we have no financial or nonfinancial interests that could be perceived as a potential conflict of interest.  \n✩✩ Acknowledgments: No source of funding was received.  \n∗ Corresponding author.  \nE-mail address: [Sajjad.ghanim57@gmail.com](Sajjad.ghanim57@gmail.com) (S.G. Al-Badri).  \n[https://doi.org/10.1016/j.radcr.2024.08.034](https://doi.org/10.1016/j.radcr.2024.08.034)  \n1930-0433/© 2024 The Authors. Published by Elsevier Inc. on behalf of University of Washington. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/))  \nextremely poor prognosis. Most cases of SCC of the pancreas are metastatic at the time of diagnosis, and therefore, they have very limited treatment options and poor prognosis [2] .  \nSCCP requires advanced imaging, including detailed histopathological examination and evaluation of tumor markers. Tumor markers are important not only for diagnosis but also for staging the cancer, prognosis assessment, and monitoring therapy effectiveness","cbCaiihMlMU0ifSH","https://ap.wps.com/l/cbCaiihMlMU0ifSH","pdf",1544946,"English","# Article history\n# Keywords\n# Case presentation\n## Emergency department findings\n## Imaging and metastasis assessment","[{\"question\":\"What does the case report focus on regarding pancreatic small cell cancer?\",\"answer\":\"It presents the first reported case of primary small cell cancer of the pancreas with positive TTF-1 tumor-marker findings and discusses the diagnostic significance of this atypical marker.\"},{\"question\":\"Why is TTF-1 important in diagnosing this case?\",\"answer\":\"TTF-1 is typically associated with lung and thyroid cancers, so its presence in a pancreatic tumor creates a diagnostic challenge. The report emphasizes careful interpretation of tumor markers in atypical small-cell presentations.\"},{\"question\":\"What clinical features led to the diagnostic workup?\",\"answer\":\"The patient had persistent epistaxis and back pain with substantial weight loss, along with abnormal laboratory results and imaging evidence of a pancreatic mass with biliary obstruction and extensive metastases.\"}]","First reported case of primary small cell cancer of the pancreas with positive TTF-1 tumor marker - Case report | PDF",1790016460,13,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c902dd3d5e40da91ea8c24fd9343acc.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0902e55ef38539293768726761c6c0ca.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/105ec34f95d6a0d70dafc8205bbd5ef4.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ca3141b26af21d038e59547326c6c6b.webp",980,1306]